Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Most loved Solace Food: What's Your Definitive Comfortable Dinner? - 2Was This Driver Simply Having Some good times Or Behaving Like An Ass?
- 3Select Your Cherished Fish
- 4Pick Your Number one breakfast food
- 5Have gravitational waves provided the first hint of primordial black holes born during the Big Bang?
- She's been a Bond girl and a mutant. Now she's grappling with Hollywood's obsession with 'eternal youth.'
- Very good quality Greens All over The Planet
- Decrease in Home Buy Credits and Home loan Renegotiating Rates: An Outline of Latest things
- Holiday season sees uptick in norovirus cases, according to CDC
- Step by step instructions to Pick the Right Dental specialist for Your Dental Inserts Technique
- Investigation reveals sperm donor passed on cancer risk to dozens of children across Europe
- Unsold Rams May Be Less expensive Than You Suspect
- Everyone knows F1 is for the girls. I wandered into the Las Vegas desert to find out why.
- A Manual for Pick High Evaluated Food Conveyance Administrations In Significant Urban communities For 2024
